Cochrane · systematic review · CD008920

Antidepressants for pain management in rheumatoid arthritis

Richards, BL, Whittle, SL, Buchbinder, R · Cochrane Database of Systematic Reviews · 2011 · Cochrane Library

MusculoskeletalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 83.3%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Tricyclic antidepressant compared to control for pain management in RA

Population: patients with pain management in RA
6 questions
OutcomeEffectEvidenceStatus / GRADE
Pain < 1 week VAS scale 0 to 100 mm
Tricyclic antidepressant vs control
no estimate extracted1 study · 30 participantsVery low
Downgraded: risk of bias, imprecision
Pain 1 to 6 weeks Any pain measurement scale
Tricyclic antidepressant vs control
no estimate extracted7 studies · 482 participantsVery low
Downgraded: risk of bias, imprecision
Pain > 6 weeks Any pain measurement scale
Tricyclic antidepressant vs control
no estimate extracted5 studies · 368 participantsVery low
Downgraded: risk of bias, imprecision
Functional Status Health Assessment Questionnaire (HAQ) scale 0 to 3
Tricyclic antidepressant vs control
no estimate extracted1 study · 28 participantsLow
Downgraded: risk of bias, imprecision
Number of Withdrawals due to Adverse Events patient interview
Tricyclic antidepressant vs control
RR 0.98 [0.59, 1.64]6 studies · 455 participantsVery low
Downgraded: risk of bias, imprecision
Total number of adverse events patient interview
Tricyclic antidepressant vs control
RR 1.83 [1.01, 3.3]6 studies · 455 participantsVery low
Downgraded: risk of bias, imprecision